AI News NQ Analysis

【5月20日は国際臨床試験の日】PPI活動の一環として開催した「統合失調症の治療とその選択肢をご家族・当事者と一緒に考えるオンラインセミナー」の開催レポートを公開

NQ スコア 78/100

AI サマリー(NQ 加工済み)

Triad Japan, a clinical trial support organization (SMO), has published a report on its online seminar titled 'Considering Schizophrenia Treatment and Options with Patients and Families,' held on April 25, 2026. Released on International Clinical Trials Day (May 20), the report details the event's success as a Patient and Public Involvement (PPI) activity, highlighting that over 90% of attendees gained a deeper understanding of the topic and over 60% developed a more positive view of clinical trials.

AI 分析

よくある質問

Q: What is International Clinical Trials Day?
A: Celebrated on May 20th, it commemorates the world's first clinical trial conducted in 1747. It is a day to recognize the importance of clinical trials and to thank the participants, whose cooperation is essential.
Q: What was the purpose of Triad Japan's online seminar?
A: The seminar aimed to address the daily concerns of individuals with schizophrenia and their families, provide accurate knowledge about treatment options and the latest trends, and explain the basics of new drug development and clinical trials.
Q: Who is Triad Japan?
A: Triad Japan is a Site Management Organization (SMO) founded in 1995 that supports medical institutions in conducting clinical trials, with a particular expertise in psychiatric and neurological fields like schizophrenia and Alzheimer's disease.
Q: What were the results of the seminar according to the post-event survey?
A: The survey showed that over 90% of participants felt their understanding of schizophrenia treatment and clinical trials had deepened. Additionally, over 60% reported that their image of clinical trials had improved after attending.
Q: What is PPI (Patient and Public Involvement)?
A: PPI is an initiative to incorporate the perspectives of patients and the public into medical research and development. Its importance is growing globally, promoting a model of 'healthcare created together with patients'.